PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 144 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $5,169,000 | -18.9% | 1,022,708 | -1.0% | 0.55% | -19.2% |
Q2 2019 | $6,376,000 | +19.9% | 1,033,328 | -9.9% | 0.68% | +27.5% |
Q1 2019 | $5,319,000 | -25.4% | 1,146,292 | -32.5% | 0.54% | -32.8% |
Q4 2018 | $7,133,000 | -34.5% | 1,698,249 | -2.2% | 0.80% | -16.6% |
Q3 2018 | $10,887,000 | -23.2% | 1,736,386 | -1.5% | 0.95% | -21.7% |
Q2 2018 | $14,174,000 | +6.8% | 1,762,978 | -0.9% | 1.22% | +1.9% |
Q1 2018 | $13,275,000 | +55.0% | 1,779,524 | +23.6% | 1.20% | +66.6% |
Q4 2017 | $8,564,000 | +77754.5% | 1,439,307 | -4.1% | 0.72% | -22.0% |
Q3 2017 | $11,000 | -99.9% | 1,500,285 | +2.3% | 0.92% | +2.2% |
Q2 2017 | $9,959,000 | -24.7% | 1,466,748 | +4.7% | 0.90% | -26.5% |
Q1 2017 | $13,228,000 | -3.8% | 1,401,257 | -12.0% | 1.22% | +35.4% |
Q4 2016 | $13,750,000 | +36.4% | 1,591,462 | -0.1% | 0.90% | +28.6% |
Q3 2016 | $10,084,000 | +268.0% | 1,593,088 | +145.4% | 0.70% | +252.0% |
Q2 2016 | $2,740,000 | +3.0% | 649,295 | +6.4% | 0.20% | -2.0% |
Q1 2016 | $2,659,000 | -31.7% | 609,963 | -4.0% | 0.20% | -33.1% |
Q4 2015 | $3,895,000 | +15.4% | 635,333 | +7.7% | 0.30% | +7.0% |
Q3 2015 | $3,374,000 | -17.7% | 589,919 | +7.4% | 0.28% | -14.2% |
Q2 2015 | $4,098,000 | -45.4% | 549,287 | -56.3% | 0.33% | -44.4% |
Q1 2015 | $7,509,000 | -5.2% | 1,255,645 | +19.9% | 0.60% | -13.5% |
Q4 2014 | $7,917,000 | +40.0% | 1,047,181 | -3.9% | 0.69% | +36.4% |
Q3 2014 | $5,656,000 | +40.8% | 1,089,745 | +16.9% | 0.51% | +44.6% |
Q2 2014 | $4,016,000 | +21.9% | 931,880 | +15.7% | 0.35% | +10.4% |
Q1 2014 | $3,295,000 | -1.1% | 805,595 | +28.9% | 0.32% | +101.9% |
Q4 2013 | $3,332,000 | – | 625,073 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
SEARLE & CO. | 60,000 | $349,000 | 0.34% |
TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |